Sneak peak at what the microbiome can do for autoimmunity. We will be holding a short course on the microbiome it’s promises during Cambridge Healthtech Institute’s 23rd International Molecular Med Tri-Con on March 6, 2016 in San Francisco – The Microbiome: Sorting the Hype from the Hope.
Joining us are the Sonnenburg Lab, the Knight Lab, Second Genome, Osel Inc., AOBiome, and Whole Biome.
Autoimmune Patient Journey The convoluted journey of patients with autoimmune and inflammatory diseases (AIIDs) has many stages. Unlike cancer, diabetes, and heart disease, there are no population screening nor public health education programs for AIIDs.
May 2022 Report This May 2022 549-page NIH report represents a significant breakthrough in autoimmune research focus. Its recommendations have major downstream implications for CDC statistics, basic research, R&D, medical education & clinical guidelines. Funded
Data Issues in Autoimmune Data for autoimmune diseases are substantially lacking and inconsistent. The US gathers no statistics on autoimmune diseases as a group, nor even national data on marquee diseases. Therefore, total autoimmune incidence
Autoimmune Diseases are Siloed by Specialty Click the arrows next to the slide to view the sources. Looks a mess, doesn’t it? It is! Autoimmune diseases are scattered across many different medical specialties, creating a